skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: NXPI along with KODIAK Science which is up more than 100% in the last month, what are your opinions of the two stocks?
About the PE ratio - on my Globe Invest it has for instance 98.4 TTM (I do not know what that is), is that number too high for you if you were looking to purchase a stock with that number? What would be a more comfortable number? Thanks for providing info that the average investor would not know. Dennis
Read Answer Asked by Dennis on December 09, 2019
Q: I recently asked you for 4-5 core picks for U.S. stocks and you kindly sent them to me that was appreciated. I am trying to keep my stocks organized by sector, which you have also helped me with and wondered what (based on your Sectors) Costco and Disney would be in?
Thank you so much
Margaret
Read Answer Asked by Margaret on December 06, 2019
Q: Please comment on the financial results of these companies. PD & ZM drop afterhours.
Thanks a lot
Read Answer Asked by Lai Kuen on December 06, 2019
Q: Hi 5i team,

Like many here, I follow the 5G theme, but there is a proliferation of participants in many facets of the technology. I own KEYS and am happy there. About a year ago, I put INSG on my watch lists. It has been dormant since then but now seems to be breaking out. I don’t see any real catalysts as such. It missed its last earnings report, but I have read some positive reviews on its 5G prospects for hot spots and SaaS. It is a smaller name and I am unlikely to buy it but I was curious as to your thoughts on it.

Thanks again for the insight.
Dave
Read Answer Asked by Dave on December 05, 2019
Q: Listed on Nasdaq as AUPH. After market close today,it was halted pending news.Later it announced positive phase 3 trail results showing that its Voclosporin is much better than Standard of Care in Lupus Nephritis.It plans to file NDA submission to FDA in 1st half of 2020,There will be a conference call @ 8.30am ET on Dec 5 .AUPH closed @ US$8.39 up 0.41 on 4.9m shares.However in After Hours trading it was @ US $18.39 to US$19.00 on total 10.6m shares.Thinking of selling my 1.5% position,p/p Can$8.33 especially if the Price is around US$18.39 to 19.00.Should I sell all or partial.Please provide your usual great advices & services.Thanks
Read Answer Asked by Peter on December 05, 2019
Q: Hello, Air Canada has been very strong for quite some time. AC's PE now sits at around 13X wheras US carriers are sitting ~7-8X PE. With the risk of oil prices spiking likely sitting at all time lows, the previous "highly cyclical sector" knock on the airline business, seems less of a problem. What are your thoughts on taking a position in an airline at this time? If you were to take a position, which would be your preference in order - and why?
Read Answer Asked by Jeff on December 04, 2019
Q: I have been very fortunate to have my second 10-bagger with ARWR bought at $4 in 2017 (after some earlier losses). It has been running very well recently but is down to-day on the news that they are issuing 4m shares at $58, well below yesterdays close of $68.66. Why would they issue new shares so far below the recent market? Is there something here to worry about?
Thanks for your great service, Bob.
Read Answer Asked by Lynn on December 04, 2019
Q: Hi there,

This is a cancer biotech focused on melanoma and cervical cancer. It sounds like several promising trials are underway. I just read about it on Seeking Alpha and CNBC shows 8 analysts covering with 5 strong buy and 3 buy recommendations with a consensus target of $35 vs a current price of $22.83. What are your thoughts regarding a position within a TFSA?

ThanksQ
Read Answer Asked by Tim on December 03, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!